# Neogen Corporation > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Neogen Corporation). ## Overview Neogen Corp develops and sells products and services used to test food, feed, and agricultural inputs for safety and quality, while also providing genomics and animal safety solutions. The company serves global food producers, laboratories, veterinarians, breeders, and distributors through a mix of direct sales and channel partners, with a strong international footprint. ## Products & services • Food safety test kits for allergens, toxins, pathogens, and sanitation • Culture media, indicator testing, and sample collection products • Genomics testing and related services for livestock and companion animals • Veterinary and animal safety products, including instruments and diagnostics • Rodent, insect, cleaner, and disinfectant control products • Training, technical support, and instrument service - **Food Safety Testing** (55%) — Disposable tests, culture media, pathogen detection, sanitation, allergen, and toxin testing products. - **Animal Safety** (25%) — Veterinary diagnostics, animal health products, genomics services, and related instruments. - **Pest Control and Hygiene** (10%) — Rodent control, insect control, cleaners, and disinfectants used in agricultural and food environments. - **Services and Support** (10%) — Genomics testing services, training, technical support, and instrument service activities. - Food safety test kits for allergens, toxins, pathogens, and sanitation - Culture media, indicator testing, and sample collection products - Genomics testing and related services for livestock and companion animals - Veterinary and animal safety products, including instruments and diagnostics - Rodent, insect, cleaner, and disinfectant control products - Training, technical support, and instrument service ## Customers Neogen sells to food processors, laboratories, and agricultural customers that need fast, reliable testing to protect product quality and compliance. In animal safety, its customers include veterinarians, livestock producers, breed associations, genetics companies, retailers, distributors, and government agencies. The company also serves end markets such as companion animals, dairy, swine, poultry, beef, aquaculture, and commercial testing labs. - **Food processors and quality labs** (primary) — Buy allergen, toxin, pathogen, sanitation, and sample testing products to verify food safety and compliance. - **Livestock and animal production customers** (primary) — Buy genomics services, diagnostics, and animal safety products to improve herd performance and health. - **Veterinarians and companion animal channels** (secondary) — Buy veterinary instruments, diagnostics, and related products for clinical use and resale. - **Distributors and retailers** (secondary) — Buy Neogen products for resale and channel reach, especially in markets without direct presence. - **Breeding, genetics, and research organizations** (secondary) — Buy genomics testing and specialized products to support breeding decisions and research workflows. - Food processors and labs buying tests for safety and compliance - Livestock producers and veterinarians using animal health products - Breed and genetics companies buying genomics and testing services - Retailers and distributors selling farm, ranch, and veterinary products - Government and commercial labs needing diagnostic and sanitation tools ## Geography Neogen generates a large share of revenue outside the United States and maintains operations in 28 countries beyond the U.S. It has direct sales and manufacturing/service presence across Europe, Latin America, Asia Pacific, Canada, and the U.S., with regional hubs in Scotland, Brazil, China, and Australia/New Zealand. International exposure matters because foreign exchange, distributor mix, and local market demand materially affect results. - **United States** (57%) — Estimated from disclosed international revenue of $448.7m out of total revenue. - **International** (43%) — Estimated from disclosed international revenue of $448.7m out of total revenue. - Operations span 28 countries outside the United States - Europe, Middle East, Africa, and India are served from Ayr, Scotland - Latin America includes offices and distribution in Mexico, Brazil, and others - Asia Pacific includes China, Japan, Korea, Australia, and New Zealand - Canada has genomics and food safety service operations ## Strategy Neogen is focused on expanding existing product sales, launching new products, and growing international revenue while continuing to acquire complementary businesses and technologies. Management also emphasizes integration of the 3M Food Safety transaction, in-house manufacturing transition for Petrifilm, and operational improvements to protect margins and support growth. The strategy is aimed at broadening the product portfolio and strengthening global distribution reach. - **Integrate the 3M Food Safety business** (short-term) — Successful integration is needed to realize synergies, stabilize operations, and support growth. - **Expand international sales** (medium-term) — International markets are a major growth lever and help diversify demand beyond the U.S. - **Develop and commercialize new products** (medium-term) — New products help offset competitive pressure and support share gains in food and animal safety. - **Improve manufacturing and supply chain control** (medium-term) — In-house production and better supply resilience can reduce disruption and support margins. - Grow existing food safety and animal safety product sales - Launch new products with added features and capabilities - Expand international sales through direct presence and distributors - Integrate the 3M Food Safety business and capture synergies - Transition Petrifilm manufacturing in-house to improve control - Pursue acquisitions and alliances that add products or technology ## Risks Neogen faces execution risk from integrating the 3M Food Safety business and from realizing expected synergies after a large transaction. It is also exposed to supplier concentration, distributor dependence, foreign exchange, tariffs, and competitive pressure across many product lines. Goodwill and intangible asset impairment risk is elevated given the recent impairment charge and the sensitivity of valuations to cash flow assumptions. - **3M Food Safety integration risk** [high] — The company still needs to integrate manufacturing and operations to realize transaction benefits. - **Supplier and single-source dependency** [high] — Some raw materials and products come from third parties or sole sources, creating disruption risk. - **Distributor channel dependence** [medium] — A meaningful portion of sales is made through distributors, which can affect demand visibility and pricing. - **Foreign exchange volatility** [high] — International revenue is large and management disclosed a material currency headwind in fiscal 2025. - **Goodwill and intangible asset impairment** [high] — A large goodwill impairment already occurred, and further declines in cash flows could trigger more charges. - 3M Food Safety integration may fail to deliver expected synergies - Supplier dependence can disrupt production and raise costs - Distributor channel reliance can weaken pricing and control - Foreign exchange can reduce reported international revenue - Goodwill and intangibles may be impaired if cash flows weaken - Competition is intense across tests, instruments, and animal safety ## Accounting The most important accounting issue is goodwill and intangible asset valuation, highlighted by a $461.4 million goodwill impairment charge in the Food Safety reporting unit. Investors should also watch revenue mix and timing across product sales versus genomics services, plus the impact of divestitures, discontinued product lines, and foreign exchange on comparability. Estimates for receivables, inventory, taxes, and fair value assumptions can materially affect reported earnings and asset values. - **Goodwill impairment** — Can materially affect net income and balance sheet equity - **Fair value estimation** — Changes in assumptions can trigger additional impairment charges - **Revenue mix between products and services** — Affects quarterly comparability and margin analysis - **Foreign currency translation** — Can change reported revenue growth without changing underlying demand - **Divestitures and discontinued product lines** — Reduces comparability across periods - Goodwill impairment can materially reduce earnings and equity - Intangible asset valuation depends on cash flow and discount rate assumptions - Service revenue from genomics may have different timing than product sales - Divestitures and discontinued products distort year-over-year comparisons - Foreign exchange affects reported international revenue and margins --- *Last updated: 2026-04-28T20:28:23.310493+00:00*